Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124896) titled 'Bipolar percutaneous endocardial septal radiofrequency ablation (Bi-PESA) treatment: A multicenter, prospective clinical study on hypertrophic obstructive cardiomyopathy' on May 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Chinese Academy of Medical Sciences Fuwai Hospital
Condition:
Hypertrophic Obstructive Cardiomyopathy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-10
Target Sample Size: Experimental Group:35;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=323021
Disclaimer: Cur...